vention
haematogen
dissemin
respiratori
pathogen
ad
mucos
defenc
ficolin
collectin
structur
function
relat
mbl
either
present
serum
express
tissu
includ
lung
limit
variat
serum
level
land
hficolin
result
presenc
polymorph
initi
studi
impact
polymorph
low
lficolin
level
seem
show
major
associ
respiratori
infect
mbl
develop
new
immunotherapeut
agent
prevent
infect
immunocompromis
host
avail
literatur
suggest
may
also
benefit
mbl
defici
patient
sever
pneumonia
review
concentr
clinic
associ
mbl
defici
suscept
respiratori
tract
infect
mannosebind
lectin
mbl
innat
immun
system
pattern
recognit
protein
kill
wide
rang
pathogen
microb
complement
activ
substanti
proport
human
popul
studi
date
mbl
defici
due
polymorph
potenti
increas
suscept
infecti
diseas
mbl
bind
numer
respiratori
pathogen
capsul
streptococcu
pneumonia
abrog
effici
bind
clinic
studi
human
shown
mbl
defici
appear
predispos
sever
respiratori
tract
infect
recent
metaanalysi
show
mbl
defici
associ
death
patient
pneumococc
infect
adjust
bacteraemia
comorbid
human
clinic
studi
also
shown
associ
mbl
defici
variou
less
common
respiratori
infect
intracellular
infect
like
tuberculosi
may
less
common
mbl
defici
reduc
opsonophagocytosi
lung
secret
contain
small
amount
mbl
potenti
suffici
activ
complement
measur
confound
dilut
inher
collect
techniqu
therefor
protein
play
role
pulmonari
immun
presum
pre
physic
cellular
solubl
innat
immun
defenc
lower
respiratori
tract
infect
crucial
maintain
lung
healthi
state
mannosebind
lectin
mbl
solubl
pattern
recognit
protein
contribut
kill
broad
rang
pathogen
microorgan
via
lectin
complement
pathway
opsonophagocytosi
defici
state
aris
polymorph
structur
promot
sequenc
gene
larg
number
associ
mbl
defici
lower
respiratori
tract
infect
document
clinic
studi
human
use
differ
definit
mbl
defici
common
associ
suggest
mbl
contribut
defenc
lung
mechanist
seen
mbl
contribut
respiratori
mucos
bloodstream
defenc
shown
bind
numer
import
respiratori
pathogen
promot
deposit
fig
cutoff
serum
level
gml
use
definit
frequenc
mbl
defici
approxim
common
immunodefici
state
may
therefor
gener
role
predispos
respiratori
tract
infect
equal
common
infecti
diseas
equal
may
individu
addit
risk
factor
mbl
defici
assum
signific
role
predisposit
infect
may
appli
diseas
respiratori
mucosa
cystic
fibrosi
patient
lower
immun
infant
window
vulner
disappear
matern
antibodi
matur
adapt
immun
respons
mbl
initi
complement
activ
via
lectin
pathway
promot
opsonophagocytosi
action
measur
work
focus
complement
pathway
structur
gene
polymorph
affect
assembl
complex
molecul
clearli
interfer
complement
activ
function
wildtyp
allel
refer
variant
b
c
collect
promot
polymorph
hl
xy
influenc
serum
level
protein
correl
haplotyp
mbl
level
function
precis
mani
individu
wildtyp
mbl
gene
still
low
unmeasur
mbl
level
function
consequ
studi
explor
infecti
diseas
associ
low
produc
genotyp
alon
may
underestim
may
mbl
definit
base
sole
low
mbl
level
g
ml
ideal
mbl
function
u
l
deposit
appropri
determin
associ
regard
import
state
mbl
level
alter
time
baselin
level
inflamm
date
mbldiseas
associ
studi
assess
genotyp
without
mbl
level
mbl
level
function
use
explor
infecti
diseas
associ
specif
note
review
less
common
entiti
mannosebind
lectin
associ
serin
proteas
defici
also
lead
mbl
function
defici
defici
less
studi
mbl
popul
diseas
associ
level
mbl
serum
protein
produc
liver
also
found
site
inflamm
albeit
level
substanti
less
blood
appreci
mbl
transcript
found
realtim
pcr
lung
tissu
mbl
present
respiratori
secret
like
repres
leakag
serum
fig
number
case
seri
investig
level
mbl
lung
essenti
shown
present
bronchoalveolar
lavag
bal
fluid
patient
pneumonia
lung
inflam
median
lung
mbl
level
gml
maxim
lung
level
mbl
case
pneumocysti
jiroveci
pneumonia
gml
compar
serum
level
rang
g
studi
measur
mbl
level
bal
fluid
make
allow
dilut
comparison
lung
protein
know
concentr
estim
though
lung
mbl
level
like
log
higher
measur
bal
therefor
least
equal
minimum
rang
gml
requir
complement
activ
data
requir
level
function
mbl
respiratori
secret
sever
pulmonari
inflamm
probabl
also
factor
control
amount
mbl
present
lung
anim
studi
document
mbl
present
lung
secret
laboratori
mice
prolong
infect
virul
influenza
viru
mbl
found
respiratori
secret
mice
infect
influenza
strain
replic
poorli
lung
mbl
bind
complement
deposit
demonstr
respiratori
pathogen
includ
haemophilu
influenza
mycoplasma
pneumonia
mycobacterium
tuberculosi
mycobacterium
avium
complex
mac
legionella
pneumophila
influenza
viru
nocardia
farcinica
recent
describ
respiratori
pathogen
sever
acut
respiratori
syndrom
coronaviru
chlamydia
pneumonia
chlamydia
psittaci
bound
mbl
inhibit
growth
cell
cultur
albeit
much
higher
inhibitori
concentr
chlamydia
trachomati
pseudomona
aeruginosa
import
pathogen
cystic
fibrosi
cf
initi
thought
bound
mbl
studi
use
flow
cytometri
analysi
bind
mbl
mous
serum
show
fact
bind
p
aeruginosa
fac
insensit
detect
mbl
bind
shown
bind
burkholderia
cepacia
gramneg
pathogen
previous
includ
pseudomonad
also
cf
pathogen
pneumococcu
one
crucial
except
definit
inform
indic
organ
polysaccharid
capsul
abrog
mbl
bind
furthermor
mous
studi
indic
classic
complement
pathway
play
paramount
role
antipneumococc
defenc
mbl
contribut
littl
model
addit
mediat
lectinpathway
complement
kill
mbl
promot
opsonophagocytosi
natur
phagocyt
receptor
mbl
remain
contenti
like
receptor
complement
receptor
type
mbl
enhanc
phagocytosi
demonstr
staphylococcu
aureu
neisseria
meningitidi
recent
studi
use
similar
methodolog
preced
show
increas
opsonophagocytosi
aureu
presenc
mbl
first
studi
assess
phagocytosi
streptococcu
pneumonia
aureu
fail
demonstr
increas
mediat
mbl
import
result
requir
verif
pneumococc
infectionmbl
associ
sought
number
studi
initi
concentr
invas
infect
pneumococc
blood
stream
infect
common
patient
oo
genotyp
subsequ
investig
similar
caucasian
patient
popul
confirm
find
spanish
patient
pneumococc
pneumonia
like
bacteraem
wildtyp
genotyp
genotyp
otherwis
predict
pneumonia
sever
measur
fine
score
recent
studi
combin
individu
patient
data
publish
studi
includ
mbl
level
well
genotyp
found
mbl
level
gml
associ
increas
death
patient
pneumococc
sepsi
adjust
pneumococc
bacteraemia
patient
comorbid
overal
avail
data
seem
associ
mbl
defici
pneumococc
infect
clinic
studi
inform
pneumococc
pathogenesi
mbl
contribut
phagocytosi
requir
conclud
certainti
associ
legionellosi
shown
associ
mbl
defici
find
somewhat
unexpect
given
due
intracellular
pathogen
two
report
identifi
low
mbl
function
risk
factor
legionellosi
outbreak
infect
australia
netherland
mbl
bind
legionella
pneumophila
albeit
low
effici
normal
mbl
level
may
expect
promot
macrophag
uptak
intracellular
kill
routin
impair
potenti
increas
frequenc
sever
legionellosi
howev
mbl
may
contribut
increas
intracellular
kill
yet
undefin
mechan
effici
complement
kill
individu
primari
antibodi
defici
mbl
genotyp
determin
assess
suscept
mycoplasma
infect
structur
gene
variant
significantli
common
among
patient
proven
mycoplasma
infect
includ
respiratori
tract
mycoplasma
pneumonia
diseas
among
healthi
control
data
associ
pneumonia
chlamydia
respiratori
tract
infect
mbl
defici
immunocompet
host
studi
communityacquir
pneumonia
concentr
specif
pathogen
still
shown
major
associ
mbl
defici
larg
prospect
studi
conduct
spanish
univers
hospit
shown
patient
defici
genotyp
increas
icu
admiss
septic
shock
death
rate
wildtyp
communityacquir
pneumonia
patient
commonest
pathogen
studi
pneumonia
patient
total
clear
associ
identifi
mbl
defici
sever
outcom
pneumococc
pneumonia
studi
link
found
defici
pneumonia
outcom
consider
number
patient
respiratori
pathogen
identifi
common
pneumonia
seri
anoth
recent
studi
link
low
mbl
level
promot
haplotyp
increas
suscept
chest
infect
prospect
studi
finnish
militari
recruit
numer
studi
use
genotyp
divid
patient
lowand
highproduc
mbl
group
shown
mbl
defici
protect
diseas
caus
tuberculosi
carriag
singl
variant
structur
allel
south
african
adult
gambian
children
full
promot
haplotyp
indic
low
mbl
product
danish
patient
protect
tuberculosi
studi
concord
find
larg
studi
southern
india
found
patient
pulmonari
tuberculosi
like
healthi
control
homozyg
variant
allel
therefor
circul
mbl
furthermor
larg
studi
tanzanian
patient
show
associ
allel
tuberculosi
suscept
obviou
differ
overal
frequenc
mbl
allel
divers
studi
popul
methodolog
differ
account
discrep
indian
group
follow
studi
anoth
document
decreas
tuberculosi
phagocytosi
wildtyp
mbl
patient
pulmonari
tuberculosi
despit
higher
mbl
level
healthi
control
observ
repeat
tuberculosi
date
also
conflict
result
regard
mblmediat
phagocytosi
case
mac
initi
mbl
shown
increas
neutrophil
phagocytosi
mac
recent
mbl
bind
mac
confirm
shown
increas
macrophag
phagocytosi
unlik
spa
spd
clinic
data
associ
mbl
mac
assist
resolut
conflict
mbl
statu
assess
children
respiratori
syncyti
viru
infect
small
brazilian
studi
respiratori
syncyti
viru
patient
lower
mbl
level
healthi
control
significantli
patient
sever
diseas
requir
hospit
admiss
mbl
level
gml
howev
data
mbl
bind
inactiv
respiratori
syncyti
viru
judg
biolog
signific
measur
associ
sar
emerg
respiratori
viral
infect
mortal
approxim
temporarili
paralys
global
travel
two
case
control
studi
chines
patient
show
associ
carriag
b
variant
allel
structur
variant
found
chines
popul
predisposit
sar
associ
low
haplotyp
death
due
sar
vitro
experi
show
mbl
bind
sar
coronaviru
mediat
deposit
inhibit
viral
infect
cell
cultur
although
numer
vitro
data
indic
mbl
abl
inactiv
influenza
viru
includ
absenc
complement
clinic
studi
show
associ
mbl
defici
influenza
interestingli
carriag
b
variant
allel
found
predict
inadequ
respons
influenza
vaccin
tnf
promot
polymorph
aspergillu
fumigatu
bound
mbl
addit
activ
lectin
complement
pathway
mbl
also
increas
phagocytosi
fumigatu
conidia
oxid
burst
polymorph
data
role
mbl
protect
invas
aspergillosi
avail
anim
model
steroidtr
balbc
mice
inocul
intranas
fumigatu
conidia
intranas
recombin
human
mbl
effect
amphotericin
b
protect
mice
lethal
invas
aspergillosi
although
human
correl
mous
model
invas
aspergillosi
small
studi
patient
chronic
necrotis
pulmonari
aspergillosi
show
increas
carriag
variant
case
compar
healthi
control
one
small
studi
nonhiv
infect
patient
cryptococcosi
show
trend
toward
mbl
function
defici
cn
rather
pulmonari
cryptococcosi
result
suggest
mbl
import
protect
dissemin
pulmonari
cryptococc
focu
rather
establish
increas
invas
fungal
infect
found
among
allogen
stem
cell
transplant
patient
either
receiv
donor
stem
cell
bear
lowproduc
genotyp
recipi
genotyp
contain
variant
allel
studi
includ
small
number
patient
probabl
invas
pulmonari
aspergillosi
still
found
strong
associ
mblmasp
variant
multivari
analysi
issu
associ
increas
infect
risk
haematopoiet
stem
cell
transplant
recipi
donor
variant
genotyp
remain
unresolv
like
major
associ
recipi
genotyp
mbl
produc
liver
addit
haematopoiet
stem
cell
transplant
use
wildtyp
cell
shown
correct
low
mbl
level
recipi
variant
genotyp
mbl
defici
appear
import
modul
sever
lung
diseas
cystic
fibrosi
danish
cf
patient
mbldefici
allel
greater
declin
lung
function
lower
surviv
control
normal
genotyp
human
studi
small
minor
cf
patient
low
level
mbl
detect
expector
respiratori
secret
high
level
neutrophil
enzym
found
sputum
cf
patient
also
abl
degrad
mbl
vitro
larg
studi
canadian
cf
patient
confirm
associ
show
lowproduc
mbl
genotyp
colonis
p
aeruginosa
earlier
age
also
signific
interact
anoth
variant
gene
transform
growth
factor
beta
previous
shown
affect
cf
progress
mbl
defici
studi
higher
rate
declin
lung
function
demonstr
group
also
found
associ
mbl
statu
cf
diseas
paramet
acceler
reduct
lung
function
found
north
american
cf
patient
mbl
level
gml
mbl
defici
regard
signific
indic
risk
progress
cf
associ
mbl
statu
chronic
obstruct
pulmonari
diseas
copd
activ
investig
patient
copd
carri
b
variant
allel
shown
like
hospit
admiss
due
infect
exacerb
airway
diseas
pulmonari
mbl
level
measur
bal
along
surfact
protein
mannos
receptor
level
found
reduc
patient
copd
markedli
activ
smoke
studi
confirm
azithromycin
produc
improv
phagocytosi
alveolar
macrophag
sought
link
collectin
activ
differ
mbl
mannos
receptor
level
induc
copd
patient
azithromycin
treatment
although
number
studi
small
contribut
mbl
improv
phagocytosi
seen
azithromycintr
copd
patient
proven
mediat
mannos
receptor
involv
interact
mbl
alveolar
macrophag
recombin
human
mbl
complementactiv
function
plasmaderiv
mbl
produc
earli
phase
clinic
studi
cancer
chemotherapi
postliv
transplant
set
data
substanti
role
mbl
pathogenesi
sever
bacteri
pneumonia
accumul
would
reason
consid
attract
target
condit
mbl
replac
given
preval
high
mortal
evid
surviv
decrement
cf
patient
variant
genotyp
suggest
patient
chronic
lifelimit
condit
could
also
benefit
intermitt
mbl
supplement
ficolin
lectin
recognit
molecul
structur
function
homolog
mbl
tabl
three
ficolin
describ
lficolin
encod
gene
mficolin
hficolin
lficolin
liverexpress
serum
molecul
mficolin
pure
tissu
ficolin
express
lung
monocyt
spleen
hficolin
also
liverexpress
serum
ficolin
addit
express
lung
bronchial
type
ii
alveolar
epitheli
cell
ficolin
gene
express
compar
realtim
quantit
pcr
found
highli
express
lung
direct
comparison
deposit
mbl
ficolin
indic
hficolin
highest
complementactiv
capac
ficolin
share
collagen
structur
mbl
homogen
subunit
assembl
oligomer
protein
carbohydr
recognit
domain
mbl
replac
fibrinogenlik
domain
region
ficolin
mediat
bind
microbi
cell
wall
carbohydr
residu
overlap
specif
mbl
lficolin
also
shown
bind
lipoteicho
acid
peptidoglycan
import
constitu
gramposit
bacteria
thu
bind
lficolin
demonstr
pneumonia
aureu
serotypespecif
manner
bind
reduc
presenc
capsul
mficolin
bind
aureu
hficolin
bind
either
pneumonia
aureu
promot
structur
sequenc
polymorph
identifi
ficolin
gene
particularli
unlik
polymorph
produc
substanti
variat
concentr
function
mbl
rang
ficolin
level
presenc
polymorph
vari
factor
absolut
defici
identifi
associ
singl
nucleotid
polymorph
low
high
serum
level
becom
appar
contrast
wide
rang
number
infecti
diseas
associ
shown
mbl
limit
studi
signific
low
lficolin
level
presenc
lficolin
singl
nucleotid
polymorph
cohort
polish
children
recurr
respiratori
tract
infect
group
patient
underli
atop
disord
significantli
like
lficolin
level
less
lower
rang
seen
healthi
control
appli
group
children
recurr
infect
detect
laboratori
abnorm
associ
polymorph
diseas
suscept
found
uk
invas
pneumococc
diseas
cohort
previous
studi
mbl
defici
associ
mbl
statu
appear
alter
neg
diseas
associ
polymorph
date
singl
nucleotid
polymorph
suffici
characteris
comment
potenti
diseas
associ
clinic
signific
overal
said
ficolin
play
overlap
role
mediat
lectin
pathway
complement
kill
mbl
presenc
ficolindefici
state
predispos
infecti
diseas
uncertain
locat
gene
lie
close
spa
spd
loci
chromosom
potenti
associ
record
polymorph
lower
respiratori
tract
infect
reflect
associ
variat
surfact
protein
gene
substanti
differ
seen
pulmonari
serum
level
spa
spd
associ
either
protein
level
genet
polymorph
suscept
respiratori
tract
infect
studi
demonstr
associ
mbl
defici
respiratori
infect
addit
test
surfact
protein
variat
interdepend
factor
remain
unresolv
one
anim
model
studi
invas
aspergillosi
compar
antiaspergillu
activ
collectin
show
mbl
recombin
spd
equival
protect
efficaci
ultim
may
presenc
mbl
blood
alveolar
capillari
pertin
measur
low
concentr
mbl
respiratori
secret
pathogenesi
sever
pneumonia
would
appropri
explan
recent
observ
increas
mortal
bacteri
pneumonia
reduc
suscept
sever
tuberculosi
patient
low
mbl
level
futur
investig
interact
mbl
present
respiratori
secret
pneumon
pathogen
may
substanti
activ
role
molecul
respiratori
mucos
defenc
inform
clinic
studi
avail
date
show
mbl
appear
play
import
role
reduc
suscept
sever
chest
infect
soon
respiratori
pathogen
enter
blood
stream
